Martek reaps regulatory omega-3 benefits

By Shane Starling in Brussels

- Last updated on GMT

Related tags: Nutrition, European food safety authority, Martek

DHA omega-3 is one of the few ingredients to benefit from the European Union nutrition and health claims process so far, and Martek's VP of regulatory affairs, Rodney Gray, looks at developments in other regulatory changes that have affected the sector.

The whole DHA sector is gaining from a European Commission-approved statement regarding the omega-3 form and infant eye and brain health.

It is a welcome development for an industry that took a body blow when one of the first European Food Safety Authority (EFSA) article 14 children’s health claim opinions ruled against a similar claim submitted by Martek back in September, 2008.

Gray tells Shane Starling of that development and highlights other regulatory changes that have affected the sector.

Related news

Related products

show more

Lutein. The Next New Vitamin?

Lutein. The Next New Vitamin?

Out of the 600 or more carotenoids found in nature, only three are found in the macula of the eye—lutein, RR-zeaxanthin and RS (meso)-zeaxanthin. These...

Effects of MaquiBright® on Improving Eye Dryness

Effects of MaquiBright® on Improving Eye Dryness

Anklam Extrakt GmbH | 15-Apr-2019 | Clinical Study

Within the course of a randomized, double-blind, placebo-controlled trial including 74 participants in total the effect of a polyphenol-rich maqui berry...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars